|
SION Sionna Therapeutics Inc 2036042 |
| Income Statement |
|
Net Income
|
2026-06-30
|
$-29,886,000.00 |
| Balance Sheet |
|
Current Assets
|
$216,130,000.00 |
|
Assets
|
$283,249,000.00 |
|
Current Liabilities
|
$10,782,000.00 |
|
Liabilities
|
$17,474,000.00 |
|
Equity
|
$265,775,000.00 |
|
Shares Out
|
45164239.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-44,060,000.00 |
|
Investing Cash Flow
|
$46,289,000.00 |
| Market Analysis |
Market Cap
|
$249,306,599.28 |
|
Price
|
$5.52 |
|
BVPS
|
5.88 |
|
PB
|
0.94 |
|
EPS
|
-0.66 |
|
FCF
|
$-44,060,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-09-01 09:32:31 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-09-14 10:01:22 |
| Apr |
May |
Jun |
| 2026-03-02 |
-0.46 |
|
|
2026-05-12 |
-0.60 |
| Jul |
Aug |
Sep |
|
|
|
|
2025-08-11 |
-0.41 |
| Oct |
Nov |
Dec |
|
|
|
|
2025-11-05 |
-0.46 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view SION documents filed with the SEC.
SION Filings
Clear